Chinese startup BrainCo has debuted a non-invasive platform that translates brain signals into robot commands in under 200 milliseconds. This technology could simplify robot training for healthcare and manufacturing, though it faces challenges with signal strength compared to invasive alternatives.
At the 2026 World Artificial Intelligence Conference in Shanghai, Chinese startup BrainCo introduced a new platform that allows users to control robotic arms using only their thoughts. The system uses a lightweight, non-invasive electroencephalography (EEG) headset to monitor brain activity. Artificial intelligence software then interprets these signals and sends commands to the robot in less than 200 milliseconds.
Advancing Human-Robot Interaction
During the demonstration, users were able to direct robotic arms to perform simple tasks like picking up cups and apples. The primary goal of this platform is to reduce the time and effort researchers spend on developing brain-controlled robotics. By streamlining the process of capturing brain signals and translating them into machine actions, the company aims to move this technology from laboratory settings into more practical applications in fields such as healthcare and manufacturing.
Improving Robot Learning Through Data
Alongside the control platform, BrainCo introduced a specialized data collection system meant to improve how robots learn. A major hurdle in modern robotics is training machines to handle delicate or complex tasks, such as folding laundry or interacting with fragile objects. By linking high-quality human brain signal data with robot movements, the company expects to generate datasets that could help robots learn these difficult tasks more effectively.
Technology Comparison and Risks
While brain-computer interfaces have been under development for decades, most high-performance systems previously required surgical implantation of devices. BrainCo’s approach offers a safer, non-invasive alternative that avoids the need for surgery. However, investors should be aware that non-invasive EEG technology generally captures weaker signals than invasive methods. This can lead to lower precision or higher error rates in complex environments. Furthermore, while the company has shown a successful demonstration, the technology's effectiveness in real-world, high-stakes industrial or medical environments will depend on its ability to maintain accuracy over time. The development remains an emerging technology, and its commercial viability will depend on the cost of the hardware, the reliability of the AI interpretation, and regulatory approvals for its use in clinical or public settings.